A recent Pew Research poll found that the proportion of Americans who said they would get a COVID-19 vaccine when it is released has dropped sharply since May. This isn’t necessarily very surprising, given the federal administration’s shenanigans with the CDC, documented in excellent reporting at Politico by Dan Diamond and the NYT by Apoorva Mandavilli. Then there’s the experience at the FDA, where emergency use authorizations were used for hydroxychloroquine and convalescent plasma before adequate evidence to support either one was available. Continue reading
Approximately 80% of COVID-19 related deaths in the United States have been among people 65 or older, according to the Centers for Disease Control and Prevention. But a research letter published online in JAMA Internal Medicine on Sept. 28 reported that more than half of COVID-19 clinical trials were “at high risk for excluding older adults,” and none included seniors as part of vaccine trials early in the pandemic.
Despite a National Institute of Health policy mandating the inclusion of older adults in appropriate clinical trials, older adults were left out more often than not as scientists struggled to get a handle on the coronavirus. Researchers found that 53% of trials they reviewed did not include those older than 65 for a variety of reasons, including compliance concerns, co-morbid conditions or technology requirements. About one in four of the trials reviewed by the researchers included an age “cutoff” that would exclude adults age 65 to 80, as UPI reported. Continue reading
If you’re a frequent user of PubMed, you have likely already noticed the new website layout and have probably noticed some differences in search options or functionality. The new PubMed was first tested in labs at the National Library of Medicine site in March of 2019 and launched officially in fall 2019, but it wasn’t formally rolled out as the default until May 2020. (The old site is still available for a little longer — at least through the end of October — here.) Continue reading
Get your flu shot. Never, perhaps, has that advice been as important for older adults to act on as this year. As winter approaches, geriatricians and infectious disease experts are increasingly concerned about the effects of even a mild flu season on an already-vulnerable older adult population, especially those in long-term care facilities.
It’s been likened to “a perfect storm,” and sailing in “uncharted waters,” according to a recent editorial in Science magazine by Edward Bologna, director of the Center for Clinical Epidemiology and Population Health at the Marshfield Clinic Research Institute in Marshfield, Wisc., and Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota in Minneapolis. Cliches aside, the reality is we have no idea what to expect when the pandemic and flu season converge, especially without a proven COVID-19 vaccine that is safe and effective in the older population. Continue reading
Missouri voters in August approved a ballot measure that would expand Medicaid eligibility to include healthy adults, beginning July 1, 2021.
According to reporting at NPR by Alex Smith, 53.25% of 1.2 million voters approved the measure, meaning Missouri joins 36 other states and the District of Columbia in expanding Medicaid under the Affordable Care Act. The approval came despite strong opposition from Republicans and rural voters, Smith wrote. Continue reading
Seven months into this pandemic, I know many health journalists may be struggling to stay on top of the unending breaking news about the pandemic. Developing national and local enterprise stories about COVID-19 can seem overwhelming.
If you haven’t already, I recommend signing up for Al Tompkins’ COVID-19 morning email. It is free and chock-full of story ideas and context that you can use for local, state, and national coverage that goes beyond a breaking news story. Continue reading